Prosecution Insights
Last updated: May 29, 2026

Examiner: RILEY, JEZIA

Tech Center 1600 • Art Units: 1637 1681 1682

This examiner grants 83% of resolved cases

Performance Statistics

83.2%
Allow Rate
+23.2% vs TC avg
1,323
Total Applications
+6.9%
Interview Lift
888
Avg Prosecution Days
Based on 1304 resolved cases, 2023–2026

Rejection Statute Breakdown

1.5%
§101 Eligibility
23.8%
§102 Novelty
39.5%
§103 Obviousness
12.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18254030 POLYMER DYES Non-Final OA Sony Group Corporation
18051344 DNA-DYE ASSEMBLY BASED SINGLE-MOLECULE FLUORESCENCE LIFETIME IMAGING PROBES Non-Final OA Massachusetts Institute of Technology
18191864 METHOD FOR MODIFYING SURFACE OF SUBSTRATE AND METHOD FOR IMMOBILIZING OLIGONUCLEOTIDE Non-Final OA Industrial Technology Research Institute
17622214 NOVEL NUCLEOTIDE ANALOGUES AND METHODS FOR USE Non-Final OA The Trustees of Columbia University in the City of New York
17600593 SEQUENCING BY SYNTHESIS WITH ENERGY TRANSFER DYE PAIRS Non-Final OA THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
18006554 ENERGY TRANSFER DYE CONJUGATES FOR USE IN BIOLOGICAL ASSAYS Non-Final OA LIFE TECHNOLOGIES CORPORATION
18041348 NUCLEOSIDE-5'-OLIGOPHOSPHATES TAGGED WITH POSTIVIELY-CHARGED POLYMERS, NANOPORES INCORPORATING NEGATIVE CHARGES, AND METHODS AND SYSTEMS USING THE SAME Non-Final OA Roche Sequencing Solutions, Inc.
18000699 METHODS AND COMPOSITIONS FOR DETECTING STRUCTURAL REARRANGEMENTS IN A GENOME Non-Final OA Roche Sequencing Solutions, Inc.
17757527 METHODS OF SEQUENCING BY SYNTHESIS USING A CONSECUTIVE LABELING SCHEME Final Rejection Roche Sequencing Solutions, Inc.
17909243 LIGHT-EMITTING PARTICLES Final Rejection Sumitomo Chemical Co., Ltd.
17743799 Amplification of RNA Detection Signals in Biological Samples Non-Final OA Akoya Biosciences, Inc.
17683975 METHODS FOR SEQUENCING NUCLEIC ACID MOLECULES Non-Final OA 13.8, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month